Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Norma Ruiz Santiago"'
Autor:
Lubna Abuqayyas, Laurence E. Cheng, Marcia Teixeira dos Santos, Barbara A. Sullivan, Norma Ruiz‐Santiago, Hui Wang, Yanchen Zhou, Vishala Chindalore, Stanley Cohen, Alan J. Kivitz, Maximilian G. Posch, Jane R. Parnes
Publikováno v:
ACR Open Rheumatology, Vol 4, Iss 10, Pp 903-911 (2022)
Objective To assess the safety and biological activity of rozibafusp alfa, a first‐in‐class bispecific antibody–peptide conjugate targeting inducible costimulator ligand (ICOSL) and B cell activating factor (BAFF), in patients with rheumatoid a
Externí odkaz:
https://doaj.org/article/5676c94a2dbb4dc3a8d16a7cdd33da21
Autor:
Paul D Miller, Jonathan D Adachi, Ben‐Hur Albergaria, Angela M Cheung, Arkadi A Chines, Evelien Gielen, Bente L Langdahl, Akimitsu Miyauchi, Mary Oates, Ian R Reid, Norma Ruiz Santiago, Mark Vanderkelen, Zhenxun Wang, Zhigang Yu
Publikováno v:
Miller, P D, Adachi, J D, Albergaria, B H, Cheung, A M, Chines, A A, Gielen, E, Langdahl, B L, Miyauchi, A, Oates, M, Reid, I R, Santiago, N R, Vanderkelen, M, Wang, Z & Yu, Z 2022, ' Efficacy and Safety of Romosozumab Among Postmenopausal Women With Osteoporosis and Mild-to-Moderate Chronic Kidney Disease ', Journal of Bone and Mineral Research, vol. 37, no. 8, pp. 1437-1445 . https://doi.org/10.1002/jbmr.4563
Patients with osteoporosis and chronic kidney disease (CKD) are at increased risk of fracture and associated negative outcomes, including increased mortality. The present post hoc analysis of two randomized, multicenter, phase 3 clinical trials-Fract
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::275b6557dc439138ab47615df0fb7c5c
https://pure.au.dk/portal/da/publications/efficacy-and-safety-of-romosozumab-among-postmenopausal-women-with-osteoporosis-and-mildtomoderate-chronic-kidney-disease(6e1159b5-a9aa-415a-afe4-1b1285f1835b).html
https://pure.au.dk/portal/da/publications/efficacy-and-safety-of-romosozumab-among-postmenopausal-women-with-osteoporosis-and-mildtomoderate-chronic-kidney-disease(6e1159b5-a9aa-415a-afe4-1b1285f1835b).html
Autor:
Wenjing Yang, Mark Vanderkelen, Angela M. Cheung, Mary Oates, Ian R. Reid, Paul Miller, Norma Ruiz Santiago, Maria Rojeski
Publikováno v:
Journal of the Endocrine Society
Postmenopausal women with osteoporosis may also have renal insufficiency. We conducted a post hoc analysis of the ARCH study to determine the efficacy and safety of romosozumab (Romo) vs alendronate (ALN) among patients with different levels of basel